GlassScriptPhysician profile
Sanjay S Jain
NPI 1205803632
$4,779.56
in general payments reported to CMS, 2019-2025
12 companies · $16.73 in 2025
The $16.73 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.09 · 2020: $47.95 · 2021: $17.98 · 2022: $279 · 2023: $4,307 · 2024: $45.22 · 2025: $16.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Travel and Lodging: $1,117 · Food and Beverage: $252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Travel and Lodging | $1,117.14 |
| Food and Beverage | $251.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,102.31 | 2023 | Da Vinci Surgical System |
| Inspire Medical Systems, INC. | $308.68 | 2022-2024 | Inspire |
| Genentech USA, INC. | $85.95 | 2019-2020 | |
| Boston Scientific Corporation | $76.53 | 2023 | Spyglass |
| Olympus America INC. | $69.03 | 2023 | Spin Vision Scope, 4.0mm Od, 2.0mm Wc |
| Abbott Laboratories | $27.46 | 2022 | |
| Abbvie INC. | $27.34 | 2023 | |
| Alcresta Therapeutics, INC. | $19.46 | 2024 | Relizorb |
| Regeneron Healthcare Solutions, INC. | $17.98 | 2021 | |
| Mylan Specialty L.P. | $17.12 | 2019 | |
| Antares Pharma, INC. | $16.73 | 2025 | Xyosted |
| Glaxosmithkline, LLC. | $10.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjay Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.